补充因子D在纤维肌痛发育中的作用和潜在机制
Xinhuan Lei1, Xiaoting Song1, Yongyong Fan1
1Department of Orthopedics, Taizhou Hospital of Zhejiang Province, Zhejiang University, Taizhou, Zhejiang, People's Republic of China.
Journal of pain research
|December 25, 2023
概括
补充因子D (CFD) 显示出作为纤维肌痛治疗新治疗点的潜力. 这项研究发现,CFD可以抑制神经病痛,为纤维肌痛患者改善生活质量提供希望.
科学领域:
- 生物医学研究的研究.
- 遗传学 遗传学 是一个
- 免疫学 免疫学 免疫学
背景情况:
- 纤维肌痛 (FM) 是慢性肌肉骨疼痛的复杂综合征,伴有体质和精神症状.
- 目前的FM治疗具有挑战性,许多患者对长期治疗没有反应.
- 新的向疗法对于减少FM患者的疼痛和改善FM患者的生活质量至关重要.
研究的目的:
- 通过生物信息学和大数据分析,确定纤维肌痛的新型治疗点.
- 研究补充因子D (CFD) 在纤维肌痛发展中的作用和机制.
主要方法:
- 生物信息学和大数据分析以选关键基因和FM的分泌因素.
- 细胞测试包括CCK-8,qRT-PCR,葡萄糖,ATP和乳酸含量测试.
- 双 luciferase 记者基因测定,以阐明 FM 中 CFD 的机制.
主要成果:
- 生物信息分析发现CFD与IL-6负相关,与IL-4正相关,这表明CFD具有抗炎作用.
- 细胞分析证实CFD逆转了BV2细胞中ATP诱导的IL-4降低和IL-6增加.
- 在实验模型中,CFD显著抑制了ATP诱导的神经病痛.
结论:
- 补充因子D (CFD) 被确定为纤维肌痛的新疗法标.
- CFD具有抗炎性质,可以抑制与FM相关的神经病痛.
- 这些发现为CFD在治疗纤维肌痛的临床应用提供了理论基础.
相关概念视频
03:03Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
01:16Clot Retraction and Fibrinolysis
6.1K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.1K